News | March 14, 2024
Cureskin secures US$ 20 million in Series B funding
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Cureskin aims to disrupt the large and growing skin and hair care industry in India
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
It is the first autotaxin inhibitor to be investigated in cancer patients
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The company will provide comprehensive response to USFDA for the observations
Subscribe To Our Newsletter & Stay Updated
